The Study Comparing the Impact of Millet-Based Diet vs. Diet Without Millet on Nutritional Health in Critically Ill Patients.

Comparison of Effect of Millet Based Diet With Millet Free Diet on Nutritional Parameters in Critically Ill Patients-A Randomized Controlled Trial. - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069677

Enrollment

120

Registered

2024-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems

Interventions

Intervention1: Giving Millet Based Ryles Tube Feed in Critically Ill Patients.: Giving Commonly Available Millet Based Ryles Tube Diet Prepared From Hospital Kitchen Will Be Given To The Critically Il

Eligibility

Inclusion criteria

Inclusion criteria: All adult aged more than 18 years patients of both medical and surgical group in whom there is no contraindications of initiating enteral feeding with expected to stay in ICU for at least 2 weeks at the point of initiation of enteral feed

Exclusion criteria

Exclusion criteria: 1. Patients in Whom Enteral nutrition is Contraindicated Like Patients on High Vasopressor/Ionotropic Support, Suspected or Proven Intestinal Obstruction or Perforation, Recent Gastrointestinal Surgery, Patients With Severe Paralytic Ileus, Gastroparesis Who are not Tolerating Enteral Feeding. 2. High Output Proximal Gastrointestinal Fistula. 3. Patients with Acute or Chronic kidney Disease and liver disease.

Design outcomes

Primary

Measure	Time frame
To Compare the Serum Protein Levels at the Time of Discharge From ICU/Death in Both Groups.Timepoint: Baseline, At Day 3, At Day 7, At Day 14 and At the Time of ICU Discharge or Death.	—

Secondary

Measure	Time frame
To Compare serum Iron, Ferritin stores and TIBC levels in both groups To Compare the Lipid profile HDL, LDL, TG, T) in both groups. To Compare the serum Procalcitonin levels in both groups. To compare the serum cytokine interleukin 6 levels in both groups. To compare the Incidence of hyperglycemia RBS more than 180 mg per dl and need of insulin therapy in both groups. To compare the Incidence of constipation, 3 days not passing stool in both groups To compare the Incidence of diarrhoea, more than 3 loose stools with volume more than 250 ml) in both groupsTimepoint: 1.5 years	—

Measure

Time frame

To Compare serum Iron, Ferritin stores and TIBC levels in both groups To Compare the Lipid profile HDL, LDL, TG, T) in both groups. To Compare the serum Procalcitonin levels in both groups. To compare the serum cytokine interleukin 6 levels in both groups. To compare the Incidence of hyperglycemia RBS more than 180 mg per dl and need of insulin therapy in both groups. To compare the Incidence of constipation, 3 days not passing stool in both groups To compare the Incidence of diarrhoea, more than 3 loose stools with volume more than 250 ml) in both groupsTimepoint: 1.5 years

—

Countries

India

Contacts

Public ContactDr Arun sahaya raja

All India Institute of Medical Sciences, Jodhpur

drnikhilkothari@gmail.com8003996948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026